UNSPSC 51262307: Viloxazine hydrochloride

This classification denotes the hydrochloride form of an adrenergic uptake inhibitor and second-generation antidepressive agent with the molecular formula C13H19NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5I5Y2789ZF, chemically known as 2-(2-ethoxyphenoxymethyl)tetrahydro-1,4-oxazine but more generally known as viloxazine, which bears US NIH Compound Identifier 5666. European Medicines Agency schedules Viloxazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00049MIG.

UNSPSC 51262307 Viloxazine hydrochloride is a Commodity code for a specific pharmaceutical active pharmaceutical ingredient used in attention-deficit and related conditions; state and local solicitations tagged under this code show minimal direct alignment with the code's nominal scope. The recent opportunities block contains two records: one for Seminole County, Florida procuring naloxone (a different pharmaceutical entirely) and safe drug deactivation systems, and one for the Texas Health and Human Services Commission issuing a Request for Information on direct-to-manufacturer prescription programs. Neither opportunity names viloxazine or reflects procurement of this specific drug formulation. The code shows little relevant recent activity, and the opportunities present appear to be misaligned with the code's intended taxonomy scope.

No state or local jurisdictions have posted active solicitations for viloxazine hydrochloride in the recent-opportunities block. The Seminole County IFB (IFB60459723LAS, response deadline Jul 26, 2023) and the Texas HHS Commission RFI (HHS0017013, response deadline Apr 3, 2026) address naloxone procurement and pharmacy benefit program design respectively, neither of which corresponds to viloxazine procurement. Business development professionals should verify code assignment accuracy in state and local procurement notices before pursuing opportunities tagged under this Commodity code, as the mismatch suggests either data entry errors or deliberate use of a narrower code to describe a broader pharmaceutical or health service category.